Written by Doc Digital Solutions Full-Spectrum Medical Marketing with Specialist Depth in Google Ads Compliance
Med spa marketing on Google in 2026 operates inside three overlapping compliance frameworks that most marketing agencies do not understand in combination: Google’s healthcare advertising policies (including the compounded medication ban that prohibits advertising compounded GLP-1, and compounded IV formulations), the FTC’s misrepresentation policy that prohibits specific result promises, and LegitScript certification requirements for practices advertising prescription drug brands like Botox by name. The July 2026 Google policy clarification now permits before-and-after imagery for cosmetic procedures with written patient marketing authorization. Meta’s February 2025 health and wellness restrictions eliminated lower-funnel conversion tracking for health and wellness advertisers including medical spas, shifting Meta strategy from direct response to video awareness and Messenger campaigns. Google Search Ads remain the highest-intent patient acquisition channel for med spas that can navigate the compliance framework correctly.
Medical spas operate across a wider range of service categories than almost any other healthcare practice type from standard cosmetic treatments like Botox and fillers to compounded medications, regenerative aesthetics, IV therapy, and medical weight loss. Each service category sits in a different position on the advertising compliance spectrum. A practice that can advertise laser treatments with relative freedom cannot advertise its compounded semaglutide programme on the same platform without violating Google’s pharmaceutical advertising policies.
Understanding where each service category falls in the compliance landscape before building any campaign is the foundation of a med spa advertising programme that stays active. Discovering these restrictions through account suspensions is significantly more expensive than understanding them before launch.
Service Category | Google Ads Status 2026 | Correct Advertising Approach |
Botox and Neuromodulators | Botox by brand name requires LegitScript certification to advertise on Google. Generic ‘neuromodulator’ or ‘injectable treatment’ can run without LegitScript but with healthcare advertiser verification. | Use ‘cosmetic injectable consultation’ or ‘neuromodulator treatment assessment’ in ad copy to avoid triggering the prescription drug name restriction. LegitScript certification enables use of Botox by name. |
Dermal Fillers | HA fillers (Juvederm, Restylane by brand) require LegitScript. Generic ‘dermal filler consultation’ does not. | ‘Volume restoration consultation’ and ‘facial filler assessment’ pass review without brand name restrictions. LegitScript certification is recommended for practices running significant filler campaign volume. |
Compounded GLP-1 and Weight Loss Injections | Google explicitly prohibits advertising unapproved pharmaceuticals. Compounded GLP-1, and compounded weight loss injections are banned from Google Ads regardless of state prescription status. | Advertise the consultation and the physician weight loss programme, not the medication. ‘Physician-supervised medical weight loss assessment’ passes. ‘Compounded semaglutide injections’ does not. |
Laser and Energy Devices | Generally permitted. Specific laser treatments (IPL, fractional, ablative) can be named in ad copy as they are cleared medical devices rather than drugs. | Procedure name plus consultation framing: ‘IPL photofacial consultation,’ ‘laser skin resurfacing assessment.’ Before-and-after imagery permitted with written patient marketing authorization post-July 2026. |
IV Therapy | Compounded IV formulations face the same restriction as other compounded medications. Standard vitamin IV drips may be advertised as wellness services. | Wellness framing: ‘IV vitamin hydration session,’ ‘nutrient infusion wellness appointment.’ Cannot name specific compounded medication formulations or imply medical treatment of a diagnosed condition. |
PRP and Regenerative Aesthetics | Falls under Google’s speculative medical treatment policy same category as stem cell therapy. Treatment claim language triggers account-level review. | Consultation-access framing required: ‘physician-supervised regenerative aesthetic assessment,’ ‘PRP microneedling consultation.’ No outcome claims. No treatment-of-condition language. |
The compounded medication advertising ban is the most actively enforced compliance issue affecting med spas on Google in 2026. Google explicitly prohibits advertising unapproved pharmaceuticals, and compounded versions of GLP-1 medications, compounded semaglutide, compounded GLP-1/GIP, and custom IV formulations are all classified as unapproved pharmaceuticals under this policy regardless of whether they are legally prescribed by physicians in the practice’s state. The FDA sent 30 warning letters to telehealth companies in February 2026 and 25 more in June 2026 specifically citing compounded GLP-1 marketing. Running Google Ads that name these compounded medications will suspend the entire account, not just the individual ad.
Med spa Google Ads campaigns require the same condition-segmented architecture that any high-compliance medical advertising environment demands. A single shared campaign serving Botox patients, laser resurfacing patients, medical weight loss patients, and PRP facial patients simultaneously produces generic messaging, compliance cross-contamination, and a CPL that does not reflect the true acquisition economics of any individual service category.
The same isolated landing page architecture that Doc Digital Solutions uses to keep stem cell Google Ads accounts active applies directly to med spa campaigns with regenerative or compounded service offerings. The complete landing page framework is detailed in the stem cell landing page guide.
Meta’s February 2025 health and wellness advertising restrictions changed the strategy for every med spa running Facebook and Instagram campaigns. Lower-funnel conversion tracking for health and wellness advertisers was eliminated practices can no longer optimise Meta campaigns for lead form completions, consultation bookings, or appointment scheduling conversion events. The creative restrictions also tightened: personal health attribute language, symptom-specific targeting, and certain before-and-after formats are restricted.
What remains available is a different but workable strategy for aesthetic practices that understand how to use the remaining campaign types.
Campaign Type | What Works Post-February 2025 | What Was Eliminated February 2025 |
Video View Campaigns | Short educational or experience videos (60 to 90 seconds) about treatments. Builds warm retargeting audiences without conversion event requirement. | Conversion event optimisation for bookings, consultations, and form completions for health and wellness advertisers. |
Reach and Brand Awareness | Broad awareness campaigns driving general brand recognition in the local market. No conversion event needed. | Leads campaign type with health and wellness service category. Lead form optimisation for medical aesthetics advertisers. |
Messenger Campaigns | ‘Send Message’ CTA sidesteps eliminated lead form conversion tracking. Patient initiates conversation in Messenger. Clinic responds directly. | Standard lead form ads optimised for form completion count. Pixel-based health condition audience targeting. |
Page Post Engagement | Promotes educational content, before-and-after posts with consent, and treatment experience content. Still available. | Personal health attribute language in ad copy: ‘Are you struggling with skin concerns?’ Symptom-specific targeting. |
The pivot that most med spas have not made on Meta is from lead form optimisation to Messenger as the conversion point. When a patient clicks ‘Send Message’ on a Meta ad and initiates a conversation in Messenger, the clinic responds directly in Messenger and there is no conversion event restriction on Messenger conversations. This sidesteps the eliminated lead form conversion tracking entirely. The inbox becomes the intake form. A spa with a staff member managing Messenger responses during business hours can book consultations from Meta advertising at a competitive cost per consultation even within the February 2025 restrictions.
Med spas compete in one of the most contested local search categories in healthcare. ‘Med spa near me,’ ‘Botox near me,’ and ‘laser treatment [city]’ are high-intent searches that multiple practices in every market are bidding on simultaneously. The practices that dominate local search results build their Google Business Profile as seriously as they build their paid campaigns.
No. Google's policy explicitly prohibits advertising unapproved pharmaceuticals, and compounded semaglutide, compounded GLP-1/GIP, and other compounded GLP-1 formulations are classified as unapproved pharmaceuticals under this policy regardless of their legal prescription status. Med spas and weight loss clinics offering these services can advertise the physician-supervised weight loss programme and consultation without naming the specific compounded medication. 'Physician-supervised medical weight loss assessment' passes Google's review. 'Compounded semaglutide injections' does not.
It depends on what the med spa advertises. LegitScript certification is required to use brand drug names in Google Ads including Botox, Juvederm, Restylane, and similar prescription-only aesthetic products. A med spa that uses generic consultation language ('injectable treatment consultation,' 'cosmetic filler assessment') in all ad copy can run Google Ads without LegitScript certification but with standard Google healthcare advertiser verification. LegitScript certification is recommended for practices running significant campaign volume across injectable categories, as it provides broader creative flexibility and reduces the risk of ad disapprovals for inadvertent prescription drug name usage.
Google clarified in July 2026 that before-and-after imagery is explicitly permitted for cosmetic procedure advertising when written marketing authorization has been obtained from the patient whose images appear in the creative. Before-and-after imagery that implies treatment of a medical disease rather than cosmetic improvement remains restricted. For med spas, this means transformation imagery showing cosmetic results skin texture improvement, facial volume restoration, body contouring results can now appear in Google Ads creative with documented patient consent, which was previously ambiguous under the broader policy language.
Med spa marketing in 2026 rewards practices that understand the compliance landscape well enough to use every available channel effectively. Google Search Ads with treatment-segmented campaigns and correct compliance framing for each service category. Meta video awareness and Messenger campaigns replacing the eliminated lead form strategy. Google Business Profile with before-and-after content and service-specific reviews. And a GoHighLevel CRM system that responds to every inquiry within minutes and nurtures leads through the 2 to 4 week decision window typical of aesthetic patients making a significant investment.
Doc Digital Solutions builds complete patient acquisition systems for medical practices across all specialties with specialist compliance knowledge in each service category. Their approach is detailed at the medical marketing agency page.
Doc Digital Solutions builds treatment-segmented Google Ads, compliant Meta campaigns, and GoHighLevel CRM automation for medical spas across the USA. Free strategy session covers your service category compliance status and treatment-specific CPL benchmarks.
docdigitalsolutions.com | (510) 306-1602 | Book a Free Strategy Session
